Privia Health Group, Inc. $PRVA Shares Bought by Public Sector Pension Investment Board

Key Points

• The Public Sector Pension Investment Board increased its stake in Privia Health Group by 27.3% in Q1, now owning approximately 0.27% of the company valued at $7.35 million.
• Privia Health Group's stock price recently increased by 2.7% to $21.27, while the firm reported a 23.4% revenue increase year-over-year despite missing EPS expectations.
• Research analysts have a consensus Buy rating for Privia Health Group, with an average price target of $28.00, highlighting optimism for future growth.

Public Sector Pension Investment Board grew its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 27.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 327,247 shares of the company's stock after buying an additional 70,209 shares during the period. Public Sector Pension Investment Board owned approximately 0.27% of Privia Health Group worth $7,347,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. US Bancorp DE lifted its holdings in Privia Health Group by 2.4% during the 1st quarter. US Bancorp DE now owns 18,487 shares of the company's stock valued at $415,000 after buying an additional 429 shares in the last quarter. Park Avenue Securities LLC boosted its holdings in shares of Privia Health Group by 3.6% in the first quarter. Park Avenue Securities LLC now owns 15,229 shares of the company's stock valued at $342,000 after purchasing an additional 532 shares during the period. CWM LLC grew its stake in Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company's stock worth $40,000 after purchasing an additional 604 shares in the last quarter. Summit Investment Advisors Inc. increased its holdings in Privia Health Group by 6.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company's stock worth $209,000 after purchasing an additional 678 shares during the period. Finally, Financial Management Professionals Inc. raised its position in Privia Health Group by 28.7% during the 1st quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock valued at $76,000 after purchasing an additional 754 shares in the last quarter. 94.48% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

PRVA has been the subject of several research analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday, May 28th. JMP Securities reissued a "market outperform" rating and set a $29.00 price target on shares of Privia Health Group in a research report on Monday, April 28th. Piper Sandler reduced their price target on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating on the stock in a research report on Monday, August 11th. Evercore ISI lowered their target price on shares of Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 9th. Finally, Barclays raised their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, Privia Health Group has an average rating of "Buy" and an average price target of $28.00.

Privia Health Group Trading Down 0.7%

PRVA traded down $0.16 on Tuesday, hitting $21.21. 110,493 shares of the company's stock were exchanged, compared to its average volume of 844,735. The firm has a market cap of $2.60 billion, a PE ratio of 192.88, a P/E/G ratio of 2.66 and a beta of 0.80. Privia Health Group, Inc. has a twelve month low of $16.47 and a twelve month high of $26.09. The stock has a fifty day moving average of $21.05 and a two-hundred day moving average of $22.75.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.03). The firm had revenue of $521.15 million for the quarter, compared to the consensus estimate of $466.97 million. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The firm's revenue was up 23.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.19 EPS. Privia Health Group has set its FY 2025 guidance at EPS. On average, analysts predict that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.